Shinsegae Department Store Denies Plans to Acquire Hugel as 'Baseless'
[Asia Economy Reporter Lim Chun-han] Shinsegae Department Store has denied reports that it is in negotiations to acquire Hugel, a domestic botulinum toxin company.
On the 17th, a Shinsegae Department Store official stated, “After confirming with internal company personnel, it was said that the information is not true.”
The previous day, a media outlet cited sources from the investment banking (IB) industry, reporting that Shinsegae Department Store is in exclusive talks with global private equity firm Bain Capital for the acquisition of Hugel’s management rights. The acquisition target is Bain Capital’s 44% stake. The acquisition amount was reported to be 2 trillion won.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Hugel is the leading domestic botox company, jointly founded in 2001 by three doctors, including a plastic surgery director and a biology PhD. After successfully developing botulinum toxin in 2010, becoming the sixth in the world to do so, the company has experienced rapid growth. In 2015, through an initial public offering (IPO), two of the co-founders sold their shares, and the remaining founder sold their stake to Bain Capital in 2017.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.